Business
Press Release Sep 13 2022
Lupin Limited has informed the Exchange about press release dated 13-Sep-2022 titled Lupin Receives Health Canada Approval for Rymti�� (biosimilar Etanercept).
About this update from Lupin Limited
[{"type":"text","content":" Lupin Limited has informed the Exchange about press release dated 13-Sep-2022 titled Lupin Receives Health Canada Approval for Rymti�� (biosimilar Etanercept). View Attachment","length":322,"tagName":"div"}]